Indian Journal of Dermatology
CASE REPORT
Year
: 2019  |  Volume : 64  |  Issue : 3  |  Page : 242--244

Apremilast in people living with HIV with psoriasis vulgaris: A case report


Bela J Shah, Deval Mistry, Navin Chaudhary 
 Department of Dermatology, B J Medical College, Civil Hospital, Ahmedabad, Gujarat, India

Correspondence Address:
Dr. Bela J Shah
139, 1st Floor, Wing No. 3, Skin OPD, Civil Hospital, Asarwa, Ahmedabad - 380 016, Gujarat
India

Psoriasis is a chronic papulosquamous skin disease that involves immune-mediated cutaneous inflammation and keratinocyte hyperproliferation. The associated immunosuppression in people living with HIV (PLHIV) with psoriasis poses a challenge to the clinician as therapeutic options are limited. Until now, there have been no documented case of apremilast therapy for HIV-associated psoriasis in India. Here, we report a case of HIV-associated psoriasis who achieved Psoriasis Area and Severity Index (PASI) 100 with apremilast therapy.


How to cite this article:
Shah BJ, Mistry D, Chaudhary N. Apremilast in people living with HIV with psoriasis vulgaris: A case report.Indian J Dermatol 2019;64:242-244


How to cite this URL:
Shah BJ, Mistry D, Chaudhary N. Apremilast in people living with HIV with psoriasis vulgaris: A case report. Indian J Dermatol [serial online] 2019 [cited 2019 Sep 22 ];64:242-244
Available from: http://www.e-ijd.org/article.asp?issn=0019-5154;year=2019;volume=64;issue=3;spage=242;epage=244;aulast=Shah;type=0